Skip to main content
. 2016 Jul 8;7(34):55231–55248. doi: 10.18632/oncotarget.10485

Figure 5. Box plots of the 7-miRNA signature in the discovery and validation phases (top two panels) and receiver operating characteristic curves for penalized logistic regressions (bottom two panels) show the discriminating capacity of the 7-miRNA signature. Rec, recurrence; NoRec, no recurrence.

Figure 5